RG
Replimune Group Inc
🇩🇪XSTU.7R8GermanyHealthcare
€11.16EURdown -0.23 (-2.02%)OpenEnd of day5:44 PM
Price€11.16-0.23 (-2.02%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US76029N1063
- CUSIP
- Not reported
Company
- Employees
- 465
- Headquarters
- Woburn, United States
- Website
- https://www.replimune.com
- CEO
- Dr. Sushil Patel Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$3.07
- P/E LTM
- -3.70
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$297.01M-5.99%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$280.55M-23.12%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.